El Nino
Hybrid (indica-leaning) · Lineage: Haze × Super Skunk
· How this profile is built: type, lineage, cannabinoid figures and the flavor, terpene and effect terms are aggregated from public cultivar records, and the summary is generated from those fields rather than copied from any third party. Per-record source citations and check dates are not stored yet. Batch-level lab numbers, when a certificate of analysis is linked below, are the verified figures.
El Nino is an indica-leaning hybrid published by Green House Seed Co, with catalogue descriptions attributing it to a blend of Haze and Super Skunk-family genetics. Released in the late 1990s and named for the Pacific weather phenomenon, the cultivar is commonly cited as a 1998 High Times Cannabis Cup winner, part of the run of trophies that built Green House's reputation alongside Great White Shark and White Rhino. It remains a recognizable back-catalogue name in the European seed market.
Profile
Flowers are typically large, dense, and rounded, with mid-green coloration, thick calyx stacking, and a generous resin layer consistent with its White-era Green House siblings. The aroma is commonly described as sweet and musky with tropical fruit, spice, and an earthy skunk base. Flavor is generally reported as heavy, sweet, and slightly spiced with a long finish. Myrcene, caryophyllene, and limonene are among the terpenes most frequently reported in lab testing of flower grown from El Nino seed stock.
Reported effects
Consumers commonly report a weighty, full-body calm arriving quickly and a mellow, unhurried headspace, generally described as an evening profile. Some consumers commonly report that the Haze side shows early as a brief bright phase before the heavier character takes over. Reported experiences vary with individual tolerance and consumption method, and these descriptions do not represent medical or therapeutic outcomes.
Consumer-reported descriptors for general information — not medical advice; no therapeutic claims are made.
Cultivation notes
Growers typically report a flowering period of roughly 8 to 9 weeks, a stout frame with strong side branching, and flower density that rewards attentive humidity management late in bloom. The cultivar is commonly described as moderately demanding, wanting steady feeding to fill out its large colas. Yields are generally described as high, one reason the name persisted in commercial catalogues well past its trophy years.
Reported effects
EuphoricHappyRelaxedSleepyUpliftedFlavors
EarthyMangoSweetWhere to find it
No business-provided menus list this strain yet — menus appear as stores claim their listings. Find licensed stores near you and ask.
Frequently asked
Did El Nino really win the High Times Cannabis Cup?
A 1998 Cannabis Cup win is commonly cited in Green House Seed Co's catalogue history and in period coverage of the Amsterdam competition circuit. As with many 1990s results, primary documentation is thin by modern standards, so this site presents the trophy as commonly cited rather than independently verified.
Why is the cultivar named after a weather pattern?
The late 1990s saw a historically strong El Nino event dominate global news, and Green House branded the release to match the moment, suggesting a force of nature in flower form. The naming is pure marketing of its era and carries no information about the plant's genetics.
Tastes like
Known descendants (1 catalogued cross list this as a parent)
Similar cultivars
Record activity
- Jul 17, 2026 — Record first published on this platform.
This platform logs changes it makes to its own record. It is not a log of the business's activity, and an absence of entries is not a finding about the business.
Spot something wrong?
Tell us which field is inaccurate and what it should be. No account needed. Nothing you submit publishes automatically — a reviewer checks every correction first, and accepted corrections are logged publicly on this page with the date. Business record fields only; please do not submit personal information about any individual.
Effects and flavors are reported by consumers and sources for general information only. This is not medical advice and makes no therapeutic claims.